AUDACITY trial to support FDA approval of the Allurion Balloon The Allurion Balloon is the world’s first and only swallowable, procedure-less gastric balloon for weight loss and was designed to ...
If weight loss with drugs that must be self-injected weekly doesn’t sound appealing — think Ozempic, Wegovy and Zepbound — there may be an intriguing new option available down the road. It's “the ...
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the presentation of four ...
Add Yahoo as a preferred source to see more of our stories on Google. As manufacturers ramp up for a GLP-1 legal battle and every food brand seems to be releasing new protein-packed products, medical ...
Allurion Technologies, Inc ALUR recently announced three scientific presentations at the American Society for Metabolic and Bariatric Surgery Annual Meeting. One of the studies highlighted the success ...
Add Yahoo as a preferred source to see more of our stories on Google. If weight loss with drugs that must be self-injected weekly doesn't sound appealing — think Ozempic, Wegovy and Zepbound — there ...
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the completion of patient enrollment in its AUDACITY trial. AUDACITY is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results